1. Home
  2. XENE vs UAA Comparison

XENE vs UAA Comparison

Compare XENE & UAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • UAA
  • Stock Information
  • Founded
  • XENE 1996
  • UAA 1996
  • Country
  • XENE Canada
  • UAA United States
  • Employees
  • XENE N/A
  • UAA N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • UAA Apparel
  • Sector
  • XENE Health Care
  • UAA Consumer Discretionary
  • Exchange
  • XENE Nasdaq
  • UAA Nasdaq
  • Market Cap
  • XENE 3.3B
  • UAA 3.7B
  • IPO Year
  • XENE 2014
  • UAA N/A
  • Fundamental
  • Price
  • XENE $38.52
  • UAA $8.19
  • Analyst Decision
  • XENE Strong Buy
  • UAA Hold
  • Analyst Count
  • XENE 7
  • UAA 21
  • Target Price
  • XENE $56.00
  • UAA $9.19
  • AVG Volume (30 Days)
  • XENE 424.9K
  • UAA 8.1M
  • Earning Date
  • XENE 02-27-2025
  • UAA 02-06-2025
  • Dividend Yield
  • XENE N/A
  • UAA N/A
  • EPS Growth
  • XENE N/A
  • UAA N/A
  • EPS
  • XENE N/A
  • UAA N/A
  • Revenue
  • XENE N/A
  • UAA $5,400,928,000.00
  • Revenue This Year
  • XENE N/A
  • UAA N/A
  • Revenue Next Year
  • XENE $1,600.08
  • UAA $1.45
  • P/E Ratio
  • XENE N/A
  • UAA N/A
  • Revenue Growth
  • XENE N/A
  • UAA N/A
  • 52 Week Low
  • XENE $35.53
  • UAA $6.17
  • 52 Week High
  • XENE $50.99
  • UAA $11.89
  • Technical
  • Relative Strength Index (RSI)
  • XENE 42.98
  • UAA 41.43
  • Support Level
  • XENE $36.90
  • UAA $7.71
  • Resistance Level
  • XENE $41.03
  • UAA $8.54
  • Average True Range (ATR)
  • XENE 1.41
  • UAA 0.33
  • MACD
  • XENE 0.03
  • UAA 0.02
  • Stochastic Oscillator
  • XENE 30.39
  • UAA 47.84

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.

About UAA Under Armour Inc.

Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and elsewhere. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. Under Armour also operates a digital fitness app called MapMyFitness. The Baltimore-based company was founded in 1996 and is led by controlling shareholder Kevin Plank.

Share on Social Networks: